+1.4%
GSK vs COO
+1.4%
0.0%
-13.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | COO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.2% | -1.8% | +1.7% | +0.3% |
| 7D | +1.7% | +4.7% | -3.1% | +0.7% |
| 30D | +7.0% | +13.9% | -6.9% | +4.4% |
| 3M | -2.7% | -14.9% | +12.3% | +1.4% |
| 6M | +1.4% | +2.0% | -0.6% | +0.1% |
| All | +1.4% | +1.4% | 0.0% | +0.1% |
Cumulative growth
Daily Returns
Daily percentage return beside COO.
Daily Out/Under-Performance
Portfolio return minus COO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × COO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded COO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling